You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 31, 2024

CLINICAL TRIALS PROFILE FOR NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02466022 ↗ Dexmedetomidine for Sedation in Total Knee Replacements Completed University of Saskatchewan Phase 3 2015-06-01 Dexmedetomidine has demonstrated benefits both in sedation, and post-operative pain control, with less respiratory depression than other common sedatives. Traditionally, dexmedetomidine has been used with a large loading dose and infusion, which has been known to cause dose-dependent negative side-effects (Abdallah et al., 2013). Single dose dexmedetomidine produces less negative side-effects, but still effective sedation and reduced post-operative pain (Jung et al., 2013). There is evidence for its benefits with general anesthesia but only a few studies exist investigating its benefits when administered for sedation purposes with spinal anesthesia, and no studies primarily examine post-operative opioid consumption. The investigators hypothesize that single dose dexmedetomidine for procedural sedation will reduce opioid consumption after total knee arthroplasty (TKA).
NCT03054922 ↗ Impact of Intraoperative Fluid Management on Electrolyte and Acid-base Variables Completed Nationwide Children's Hospital Phase 3 2017-02-23 During major surgical procedures, intravascular volume is maintained with the administration of isotonic fluids such as Lactated Ringers (LR), Normal Saline (NS) or Normosol-R. All three of these fluids are in common clinical use for this purpose. As large volumes of NS may result in a dilutional acidosis and an increasing base deficit, it may cloud clinical decision making when resuscitative efforts are guided by acid-base status on routine arterial blood gas analysis. This is a prospective, randomized study to evaluate changes in acid-base and electrolyte (sodium, potassium, calcium) status with the use of various isotonic fluids for intraoperative resuscitation.
NCT03537898 ↗ Balanced Solutions and Plasma Electrolytes Recruiting Vanderbilt University Medical Center Phase 3 2018-06-01 The administration of intravenous fluids is ubiquitous in the care of the critically ill. Commonly available isotonic crystalloid solutions contain a broad spectrum electrolyte compositions including a range chloride concentrations. Recent prospective, randomized trials have shown improved patient outcomes with the use of balanced crystalloids compared to saline. There have not been large randomized studies comparing acetate buffered balanced crystalloids to non-acetate buffered balanced crystalloids in the critically ill. BASE will be a pilot study for a large, cluster-randomized, multiple-crossover trial enrolling critically ill patients from the Medical ICU at Vanderbilt University from June 2018 until January 2019. The primary endpoint will be plasma bicarbonate concentration between Intensive Care Unit admission and hospital discharge.
NCT03591289 ↗ Does Depth of Neuromuscular Blockade (NMB) Affect Surgical Conditions in Obese Patients Undergoing Robotic Surgery Withdrawn Rainer Lenhardt Phase 4 2018-02-01 A prospective, randomized, outcome trial to evaluate, if depth of neuromuscular blockade (NMB) will affect surgical conditions and postoperative pain based on the degree of neuromuscular block during robotic surgery for gynecological and urologic procedures in obese and non-obese patients.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER

Condition Name

Condition Name for NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER
Intervention Trials
Critical Illness 1
GYN Disorders 1
Post-operative Pain for Total Knee Arthroplasty 1
Urologic Diseases 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER
Intervention Trials
Pain, Postoperative 1
Urologic Diseases 1
Genital Diseases, Female 1
Critical Illness 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER

Trials by Country

Trials by Country for NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER
Location Trials
United States 3
Canada 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER
Location Trials
Kentucky 1
Tennessee 1
Ohio 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER

Clinical Trial Phase

Clinical Trial Phase for NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER
Clinical Trial Phase Trials
Phase 4 1
Phase 3 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER
Clinical Trial Phase Trials
Completed 2
Recruiting 1
Withdrawn 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER

Sponsor Name

Sponsor Name for NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER
Sponsor Trials
University of Saskatchewan 1
Nationwide Children's Hospital 1
Vanderbilt University Medical Center 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER
Sponsor Trials
Other 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.